JP2005509160A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005509160A5 JP2005509160A5 JP2003542928A JP2003542928A JP2005509160A5 JP 2005509160 A5 JP2005509160 A5 JP 2005509160A5 JP 2003542928 A JP2003542928 A JP 2003542928A JP 2003542928 A JP2003542928 A JP 2003542928A JP 2005509160 A5 JP2005509160 A5 JP 2005509160A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- polypeptide
- functional derivative
- binding
- test compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 8
- 229920001184 polypeptide Polymers 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- 241000711549 Hepacivirus C Species 0.000 claims 3
- 101000740659 Homo sapiens Scavenger receptor class B member 1 Proteins 0.000 claims 3
- 102000051417 human SCARB1 Human genes 0.000 claims 3
- 239000005557 antagonist Substances 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34450401P | 2001-11-09 | 2001-11-09 | |
| PCT/EP2002/012272 WO2003040726A2 (en) | 2001-11-09 | 2002-11-01 | Screening for hepatitis c virus entry inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005509160A JP2005509160A (ja) | 2005-04-07 |
| JP2005509160A5 true JP2005509160A5 (enExample) | 2006-01-05 |
Family
ID=23350803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003542928A Withdrawn JP2005509160A (ja) | 2001-11-09 | 2002-11-01 | Ｃ型肝炎ウイルス侵入阻害剤のスクリーニング |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050019751A1 (enExample) |
| EP (1) | EP1444523B1 (enExample) |
| JP (1) | JP2005509160A (enExample) |
| AT (1) | ATE491952T1 (enExample) |
| CA (1) | CA2465731A1 (enExample) |
| DE (1) | DE60238633D1 (enExample) |
| WO (1) | WO2003040726A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0315248D0 (en) * | 2003-06-30 | 2003-08-06 | Hoffmann La Roche | HCV regulated protein expression |
| AU2005262006B2 (en) * | 2004-07-08 | 2011-01-27 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replication |
| WO2006103493A1 (en) * | 2005-03-29 | 2006-10-05 | Epixis | Methods for enhancing the potency of hcv neutralizing antibodies |
| EP1832283A1 (en) * | 2006-03-09 | 2007-09-12 | Cenix Bioscience GmbH | Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| WO2007101710A1 (en) * | 2006-03-09 | 2007-09-13 | Cenix Bioscience Gmbh | Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| WO2008013918A2 (en) * | 2006-07-26 | 2008-01-31 | Myelin Repair Foundation, Inc. | Cell cycle regulation and differentiation |
| WO2010039649A2 (en) * | 2008-10-03 | 2010-04-08 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Flavivirus-based system for production of hepatitis c virus (hcv) |
| US10781382B2 (en) * | 2015-11-12 | 2020-09-22 | Sabic Global Technologies B.V. | Methods for producing aromatics and olefins |
| CN112121168B (zh) * | 2020-04-09 | 2022-03-04 | 中国人民解放军军事科学院军事医学研究院 | 一种抑制剂在制备治疗SARS-CoV-2肺炎及其并发症的药物中的应用 |
| WO2024052379A1 (en) * | 2022-09-07 | 2024-03-14 | United Kingdom Research And Innovation | Therapeutic agents for metabolism-associated diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1270939B (it) * | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
| US5925333A (en) * | 1995-11-15 | 1999-07-20 | Massachusetts Institute Of Technology | Methods for modulation of lipid uptake |
| US5998141A (en) * | 1997-07-10 | 1999-12-07 | Millennium Pharmaceuticals, Inc. | Intronic and polymorphic SR-BI nucleic acids and uses therefor |
-
2002
- 2002-11-01 WO PCT/EP2002/012272 patent/WO2003040726A2/en not_active Ceased
- 2002-11-01 EP EP02802643A patent/EP1444523B1/en not_active Expired - Lifetime
- 2002-11-01 JP JP2003542928A patent/JP2005509160A/ja not_active Withdrawn
- 2002-11-01 DE DE60238633T patent/DE60238633D1/de not_active Expired - Lifetime
- 2002-11-01 AT AT02802643T patent/ATE491952T1/de not_active IP Right Cessation
- 2002-11-01 US US10/494,555 patent/US20050019751A1/en not_active Abandoned
- 2002-11-01 CA CA002465731A patent/CA2465731A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tio et al. | Two dimensional VOPBA reveals laminin receptor (LAMR1) interaction with dengue virus serotypes 1, 2 and 3 | |
| Allison et al. | Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E | |
| JP2010529860A5 (enExample) | ||
| WO2008039818A3 (en) | Modified t cell receptors and related materials and methods | |
| JP2005509160A5 (enExample) | ||
| PL363071A1 (pl) | Sposoby i kompozycje dla zmniejszenia replikacji HIV-1 | |
| JP2007529204A5 (enExample) | ||
| CN112028977A (zh) | 一种新型冠状病毒n蛋白抗原变体及其在新型冠状病毒抗体检测中的应用 | |
| BECK‐SICKINGER et al. | A novel cyclic analog of neuropeptide Y specific for the Y2 receptor | |
| JP2004536585A5 (enExample) | ||
| WO2005087811A3 (en) | Estrogen receptors and methods of use | |
| JP2008521795A5 (enExample) | ||
| WO2005023992A3 (en) | Compositions and methods for inhibiting white spot syndrome virus (wssv) infection | |
| Johansson et al. | Tetrapeptides as potent protease inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase) | |
| JP2003530821A5 (enExample) | ||
| CN104136455A (zh) | 抗hiv-1多肽及其用途 | |
| JP4041541B2 (ja) | エピトープｙｐｙｄｖｐｄｙａに対するモノクローナル抗体、その製造方法および使用方法 | |
| CN101289500A (zh) | 病毒感染的长效融合肽抑制剂 | |
| CA2435097A1 (en) | Peptides exibiting affinity for the viral protein gp120, and use of the se peptides | |
| ATE294816T1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| WO2007029262A3 (en) | Compositions and methods using same for the detection of viruses | |
| JP2009525741A5 (ja) | HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド | |
| Li et al. | NACA as a potential cellular target of hepatitis B virus preS1 protein | |
| Lee et al. | Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D-and L-cysteine at positions i and i+ 3, respectively, derived from HIV-1 gp41 C-peptide | |
| JP2003514549A5 (enExample) |